CTS Corporation (CTS) Bundle
You're looking for a clear signal in the noise of a mixed market, and CTS Corporation (CTS) just gave us a fresh set of numbers to work with, right after their Q3 2025 earnings release in late October. The headline here is that the company's strategic pivot is defintely paying off in the diversified markets, where sales jumped a strong 22% year-over-year, which is a powerful counter-trend. But, you still have to be a realist: the transportation sector remains a headwind, pulling down overall Q3 sales growth to 8%, totaling $143 million. Here's the quick math: management is confident enough in the core business to narrow their full-year 2025 guidance, projecting sales between $535 million and $545 million, with adjusted diluted EPS targeted at $2.20 to $2.25, plus they just announced a new $100 million share buyback plan. We need to unpack this-is the robust 38.9% adjusted gross margin enough to offset the one-time $4.2 million EPA charge that hit net income, and what does this diversification momentum mean for your investment thesis?
Revenue Analysis
You need to see where the money is actually coming from to judge CTS Corporation (CTS)'s underlying health, and the big takeaway is a strategic pivot is working, even if it's masking weakness in a core market. The company is projecting full-year 2025 sales in the range of $535 million to $545 million, which signals a modest rebound after a tough 2024.
Here's the quick math: CTS reported annual revenue of $515.77 million in 2024, a 6.30% drop from the prior year. The 2025 guidance implies a year-over-year revenue growth of roughly 3.7% to 5.7%, which is solid, but still lags the broader US Electronic Components industry's growth rate. This growth is defintely driven by their long-term strategy to diversify away from cyclical markets.
CTS's revenue comes from selling custom engineered solutions that 'Sense, Connect and Move,' which translates to a mix of sensors, actuators, and electronic components. They serve four main end markets, but the contribution from those markets is changing fast. This is the most important trend to watch.
- Diversified End Markets: This segment includes Medical, Industrial, and Aerospace & Defense. It's the growth engine.
- Transportation End Market: This segment, historically a major component, is facing headwinds.
The most significant change in CTS's revenue stream is the increasing dominance of the Diversified End Markets. In the second quarter of 2025, these segments accounted for 55% of overall company revenue, a clear majority. Sales in these diversified markets grew by a strong 22% year-over-year in Q3 2025, with Aerospace and Defense seeing a massive 39% increase in Q1 2025 alone. This is where the company is putting its capital and focus, and it's paying off.
The flip side is the Transportation End Market, which saw sales decrease by 7% year-over-year in Q3 2025. This decline is a drag on overall growth, but the strength in the diversified segments is more than compensating for it. The company's geographic revenue distribution, based on recent Last Twelve Months (LTM) data, is also instructive:
| Region | Contribution to Revenue (LTM) |
|---|---|
| North America | 59% |
| Asia | 25% |
| Europe | 16% |
This heavy reliance on North America, making up nearly three-fifths of sales, means you need to keep a close eye on US industrial and defense spending trends. For a deeper dive into the company's valuation, check out our full report: Breaking Down CTS Corporation (CTS) Financial Health: Key Insights for Investors.
Profitability Metrics
If you're looking at CTS Corporation (CTS), the first question is simple: are they making good money, and is that improving? The short answer is yes, absolutely, but you need to understand how they are doing it. Their profitability metrics for the 2025 fiscal year show a company that is successfully navigating a tough market by executing a clear diversification strategy.
For the trailing twelve months (TTM) ending in Q3 2025, CTS Corporation's margins are significantly outperforming the electronic components industry average. This isn't just luck; it's a direct result of shifting their sales mix away from softer markets like transportation.
- Gross Profit Margin: TTM stands at 38.2%.
- Operating Profit Margin: TTM is a robust 14.86%.
- Net Profit Margin: TTM reached 11.14%.
Here's the quick math: the company is keeping nearly 15 cents of every dollar in revenue as operating profit (before interest and taxes). That's a powerful engine.
Outperforming the Industry Benchmark
To be fair, a raw number like 11.14% Net Profit Margin doesn't mean much until you put it next to its peers. When you compare CTS Corporation's performance to the Electronic Components industry average as of November 2025, the picture becomes very clear.
CTS Corporation is generating nearly four times the net profit margin of the average electronic components manufacturer. This is a defintely a key differentiator for investors.
| Profitability Metric | CTS Corporation (TTM/Q3 2025) | Industry Average (Electronic Components, Nov 2025) | Outperformance |
|---|---|---|---|
| Gross Profit Margin | 38.2% | 34.4% | +3.8 percentage points |
| Net Profit Margin | 11.14% | 3.1% | +8.04 percentage points |
Operational Efficiency and Margin Trends
The trend in profitability is upward, which is what you want to see. The adjusted gross margin improved slightly to 38.9% in the third quarter of 2025, continuing a positive trajectory. This operational efficiency is being driven by strategic shifts, not just cost-cutting.
The core of the margin expansion comes from CTS Corporation's strategic focus on diversification into higher-margin end markets like aerospace & defense, industrial, and medical. In Q3 2025, sales to these diversified end markets grew by a strong 22% year-over-year, which helped offset a 7% decline in the transportation sector. This favorable mix of sales is directly translating to a better gross margin.
What this estimate hides is the impact of one-time charges. For instance, the GAAP net income for Q3 2025 was $14 million, resulting in a 9.6% net margin. However, this included an extraordinary $4.2 million charge related to an EPA past cost recovery claim. Adjusting for that one-off item gives you a cleaner view of core operating performance. Looking ahead, the company narrowed its full-year 2025 sales guidance to a range of $535 million to $545 million and adjusted diluted earnings per share (EPS) to $2.20 to $2.25. This tightened guidance reflects confidence in their ability to maintain margin discipline despite persistent weakness in the transportation market.
If you want to dig deeper into the investor base driving these results, you can check out Exploring CTS Corporation (CTS) Investor Profile: Who's Buying and Why?.
Debt vs. Equity Structure
CTS Corporation (CTS) maintains a remarkably conservative and healthy capital structure, relying far more on shareholder equity than on debt to finance its operations and growth. This low-leverage approach translates into a significantly lower risk profile than many of its industry peers, which is a major positive for investors.
The company's financial leverage, or the mix of debt and equity, is very light. As of the third fiscal quarter ending September 30, 2025, CTS Corporation's total debt stood at approximately $118.2 million, while its total common equity was around $547.7 million. This is a strong balance sheet that prioritizes stability over aggressive financial engineering.
Here's the quick math on that leverage: CTS Corporation's Debt-to-Equity (D/E) ratio for Q3 2025 was approximately 21.6% (or 0.216). To be fair, this is a very low number. The median D/E ratio for the Electronic Components and Accessories industry in 2024 was 0.68, meaning CTS Corporation is operating with about one-third of the leverage of the average peer. They simply don't need to borrow much.
The company's debt is primarily structured through a Revolving Credit Facility, which is a flexible, bank-issued credit line, and its long-term debt balance was reported at $88,000,000 at the end of the second quarter of 2025. This revolving facility is a common way for companies to manage working capital and fund smaller, strategic acquisitions without the complexity of a bond issuance. It shows a preference for accessible, manageable credit over large, fixed-term obligations.
CTS Corporation's capital allocation strategy clearly balances organic growth and acquisitions with direct returns to shareholders, which is a key signal of financial strength. In 2025 year-to-date, the company has already returned $26,000,000 to shareholders through a combination of dividends and stock buybacks. This is the hallmark of a company generating strong cash flow and choosing to reward owners rather than just service debt.
- Total Debt (Q3 2025): $118.2 million
- Debt-to-Equity Ratio (Q3 2025): 21.6%
- Industry Median D/E: 0.68
What this low leverage tells you is that CTS Corporation has ample financial flexibility. With a cash balance of $99,000,000 at the end of Q2 2025, they have more cash on hand than long-term debt. This good liquidity means they are defintely well-positioned to support strategic acquisitions or weather any unexpected market downturns without risking a debt crisis.
For a deeper dive into who is backing this low-leverage strategy, you should check out Exploring CTS Corporation (CTS) Investor Profile: Who's Buying and Why?
Liquidity and Solvency
You need to know if CTS Corporation (CTS) has enough immediate cash to cover its bills, and honestly, the answer is a solid yes. Their liquidity position, which is their ability to meet short-term obligations, is defintely strong, driven by high current and quick ratios and robust operating cash flow through the third quarter of 2025.
The quick math shows a healthy buffer. For investors, this means the company isn't scrambling for cash or relying heavily on new debt to keep the lights on. They are self-funding their growth and managing their working capital well. You can see the full breakdown of their financial health in our comprehensive analysis, Breaking Down CTS Corporation (CTS) Financial Health: Key Insights for Investors.
Assessing CTS Corporation's Liquidity
The core indicators of short-term financial health-the current and quick ratios-paint a very reassuring picture. As of the trailing twelve months (TTM) ending Q3 2025, CTS Corporation's Current Ratio sits at 2.64. This means the company holds $2.64 in current assets (cash, receivables, inventory) for every $1.00 in current liabilities (bills due within a year). A ratio over 2.0 is generally excellent, so this is a clear strength.
Even better is the Quick Ratio (or acid-test ratio), which excludes inventory-the least liquid current asset-and it registers at a strong 2.12 for the same period. This tells you that even if CTS Corporation couldn't sell a single component of its inventory, it still has more than double the liquid assets needed to cover all its short-term debt. That's a textbook definition of low liquidity risk.
Here's the quick math on their working capital:
- Total Current Assets (Sep '25 TTM): $276.18 million
- Total Current Liabilities (Q3 '25): $104.770 million
- Working Capital: $171.41 million
This $171.41 million in working capital is a substantial buffer, and the trend of these high ratios indicates a disciplined approach to inventory and accounts receivable management. They are not letting capital get tied up unnecessarily.
Cash Flow Statement Overview and Trends
The cash flow statement confirms this strength, showing the company is generating plenty of cash from its core business operations. For the nine months ended Q3 2025, CTS Corporation generated $73 million in net cash from operating activities. This is the lifeblood of the company, and it's positive and strong.
The other two cash flow sections show how this cash is being deployed:
- Investing Cash Flow: The TTM cash flow from investing activities shows a net cash used of $18.64 million. This negative number is a positive sign, as it primarily represents capital expenditures-money spent on new property, plant, and equipment-which is necessary investment for future growth and capacity.
- Financing Cash Flow: The company is actively returning capital to shareholders. In Q3 2025 alone, they repurchased 400,000 shares for approximately $17 million. This consistent use of cash for share buybacks and dividends, rather than for debt repayment (since their long-term debt is manageable at $91 million as of Q3 2025), signals management confidence in sustained operating cash generation.
The only minor caveat is that the operating cash flow in Q3 2025 was $29 million, a decrease from the prior year's quarter. Still, the year-to-date figure is strong, and the overall picture is one of excellent liquidity and a healthy balance sheet. There are no immediate liquidity concerns; the company has the financial flexibility to weather any near-term market slowdowns and continue its strategic investments.
| Liquidity Metric (as of Q3 2025) | Value (in millions USD) | Interpretation |
|---|---|---|
| Current Ratio | 2.64 | Strong ability to cover short-term debt. |
| Quick Ratio | 2.12 | Very high liquid asset coverage, excluding inventory. |
| Working Capital | $171.41 | Substantial financial buffer. |
| Operating Cash Flow (YTD) | $73 | Strong cash generation from core business. |
Valuation Analysis
You're looking at CTS Corporation (CTS) and wondering if the market is giving you a fair shake. Based on the latest fiscal year 2025 data, my take is that CTS is currently priced as a reasonable Hold, leaning toward fairly valued, but with a clear ceiling and floor established over the last year. We're not seeing a deep discount or a massive overvaluation right now.
The stock has definitely seen better days, dropping about -23.36% over the last 12 months, which is a significant correction from its 52-week high of $57.49. Still, the stock price of approximately $41.93 as of mid-November 2025 is well above its 52-week low of $34.02. The market is clearly digesting the company's narrowed 2025 guidance for adjusted diluted earnings per share (EPS) of $2.20-$2.25 and sales of $535-$545 million.
Key Valuation Multiples
To be fair, the valuation multiples suggest CTS is trading at a premium to its future earnings potential, but not excessively so. Here's the quick math on the core ratios, which help us gauge if the company is cheap or expensive relative to its fundamentals:
- Price-to-Earnings (P/E) Ratio: The trailing P/E is 20.89, but the forward P/E drops to 17.52. This forward number is more important, as it suggests the market expects earnings growth to catch up to the current price, making the stock look cheaper a year out.
- Price-to-Book (P/B) Ratio: At 2.20, this is reasonable for a technology-driven manufacturer. It means you're paying $2.20 for every dollar of the company's net asset value (book value).
- Enterprise Value-to-EBITDA (EV/EBITDA) Ratio: This ratio, which factors in debt and cash, stands at 10.39. This is a healthy, sustainable level that doesn't scream overvaluation, especially for a firm with strong cash flow.
These ratios, particularly the forward P/E of 17.52, suggest the stock is priced for modest, not explosive, growth. It defintely looks fairly valued.
Dividend and Analyst Sentiment
The dividend story for CTS Corporation is one of stability, not income growth. The company pays an annual dividend of $0.16 per share, which translates to a modest dividend yield of about 0.39%. What matters more is the safety of that payout, and the payout ratio is exceptionally low at around 8.12% based on trailing earnings. This means the dividend is incredibly secure, but don't expect it to drive your total return.
When you look at the analyst community, the consensus is generally a Hold. One analyst recently set a price target of $47.00, which suggests a decent upside from the current price, but the overall sentiment is that the stock is fairly valued at this time. The key for investors is to watch for how the company's diversification strategy-moving away from a heavy reliance on the transportation sector-translates into the 2026 earnings per share (EPS). You can dig deeper into the institutional interest by Exploring CTS Corporation (CTS) Investor Profile: Who's Buying and Why?
Risk Factors
You're looking for the clear risks that could derail CTS Corporation's (CTS) current trajectory. While the company is executing well on its diversification strategy, there are still some heavy-lifting challenges, both internal and external, that we need to map out. The biggest near-term risk remains the softness in the transportation sector, but global politics and regulatory costs are also in the mix.
The company's primary internal headwind is the transportation end-market decline, which saw sales drop by 7% year-over-year in Q3 2025. This is a significant drag, even as their diversified markets soar. Plus, the slight miss on Q3 2025 adjusted diluted earnings per share (EPS) of $0.60, a penny below the prior year's $0.61, shows how quickly profitability can be pressured, even with a revenue beat of $143 million.
Here's a quick look at the core risks highlighted in their recent filings and earnings reports:
- Market Concentration Risk: Reliance on the cyclical transportation market, despite diversification efforts.
- Geopolitical Volatility: U.S.-China trade tensions and potential tariffs on key manufacturing locations like China and Mexico.
- Supply Chain Constraints: Ongoing shortages of critical raw materials and electronic components, especially semiconductor chips and resin.
- Regulatory and Environmental Costs: The Q3 2025 GAAP net income of $14 million was hit by a one-time $4.2 million charge related to an EPA past cost recovery claim.
- M&A Integration: Unanticipated issues in fully integrating recent acquisitions, like SyQwest, LLC.
The good news is that CTS Corporation is defintely not sitting still; their mitigation strategy centers on a decisive pivot. Their sales to the diversified end markets-aerospace/defense, industrial, and medical-surged 22% year-over-year in Q3 2025, now making up 59% of total revenue. This strategic shift is their biggest defense against cyclical downturns in transportation.
Their financial buffer is also worth noting: the company maintains a strong cash balance, reported at around $250 million as of Q1 2025, which gives them capital flexibility for acquisitions and R&D investment in new products like the eBrake™. This diversification is the clearest action to offset the transportation sector's weakness.
To understand the full scope of their long-term vision and commitment to high-growth sectors, you should review their Mission Statement, Vision, & Core Values of CTS Corporation (CTS).
The table below summarizes the key financial and operational risks we've seen play out in the 2025 fiscal year data:
| Risk Category | 2025 Fiscal Year Data Point (Q3 Update) | Impact |
|---|---|---|
| Market/Operational | Transportation Sales Decline: 7% YoY in Q3 2025 | Puts pressure on overall revenue growth and margins. |
| Regulatory/Financial | Q3 2025 Net Income Charge: $4.2 million for EPA claim | Directly reduces GAAP net income, highlighting environmental compliance cost risk. |
| Financial/Profitability | Q3 2025 Adjusted Diluted EPS: $0.60 (down from $0.61 in Q3 2024) | Indicates profitability is challenged by headwinds like U.S. tax legislation and operational costs. |
The clear action for investors is to monitor the growth rate of the diversified markets against the transportation decline. If the diversified segment's 22% growth rate slows, the overall risk profile rises quickly.
Growth Opportunities
You're looking for where CTS Corporation (CTS) will generate its next wave of returns, and the answer is clear: the company is executing a deliberate pivot away from its volatile transportation business and into higher-margin, diversified end markets. This strategy is defintely paying off, as the $535 million to $545 million sales guidance for the 2025 fiscal year-narrowed from an earlier range-shows a focused, achievable target.
The core of the growth story is diversification, which is how they are managing to grow even with a soft automotive sector. Diversified end markets, which include aerospace/defense, industrial, and medical, saw a robust 22% year-over-year sales growth in the third quarter of 2025. That's a huge jump, and it's where you should focus your attention. The company is aiming for a long-term 10% organic and inorganic growth rate.
Here's the quick math: the growth in these diversified sectors is more than offsetting the approximately 7% decline seen in the traditional transportation sector during the same period.
- Aerospace/Defense: Sales grew 23% in Q3 2025, significantly bolstered by the SyQwest acquisition in 2024.
- Industrial: This segment saw 21% year-over-year growth in Q3 2025, driven by new wins in automation and Electric Vehicle (EV) charging solutions.
- Medical: Focus areas include therapeutic and portable ultrasound applications, leveraging their precision sensor technology.
Product Innovation and Strategic Moves
The company's competitive advantage isn't just a global footprint; it's their deep technical expertise in custom engineered solutions-products that sense, connect, and move. They are translating this into concrete product innovations that align with major industry megatrends like electrification and automation. For example, the development of next-generation smart actuators and smart sensors for autonomous systems positions them for future growth in both industrial and electric vehicle markets.
On the capital front, management is signaling confidence with a new $100 million share repurchase program announced in November 2025, showing a commitment to returning capital to shareholders. Plus, they are using a strong balance sheet to support acquisitions, like the SyQwest deal, which immediately boosted their defense capabilities. This is smart capital allocation in action.
To be fair, the transportation sector softness is a near-term risk, but the company's strategic shift is mitigating it. The full-year 2025 adjusted diluted Earnings Per Share (EPS) is projected to be between $2.20 and $2.25, a tight range that reflects management's confidence in their operational efficiency and margin expansion efforts. What this estimate hides is the potential for further margin improvement as the higher-growth diversified markets take up a larger share of the revenue mix.
Here is a snapshot of the 2025 financial guidance and key growth metrics:
| Metric | 2025 Full-Year Guidance (Narrowed) | Q3 2025 Performance Highlight |
|---|---|---|
| Net Sales Projection | $535M - $545M | Q3 Sales of $143M |
| Adjusted Diluted EPS | $2.20 - $2.25 | Q3 Adjusted EPS of $0.60 |
| Diversified Market Sales Growth | N/A (Strategic Focus) | 22% Year-over-Year |
| Industrial Sales Growth | N/A (Strategic Focus) | 21% Year-over-Year |
The company also emphasizes its Mission Statement, Vision, & Core Values of CTS Corporation (CTS)., which underpins their Focus 2025 strategic plan for long-term value creation. Their robust operating cash flow, which hit $28 million in Q2 2025, gives them the necessary dry powder for continued R&D investment and strategic mergers and acquisitions (M&A).
Next step: Finance should model the impact of a sustained 20%+ growth rate in the diversified segments on the 2026 gross margin forecast by the end of the quarter.

CTS Corporation (CTS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.